English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Genetic data may improve prediction of steroid side effect risk, study finds

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

GLP-1 therapy linked to increased dizziness and fainting in patients on blood pressure drugs

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

New guideline recommends tailored care for children with precocious puberty

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Study finds physical activity drops after starting GLP-1 obesity medications

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Diabetes increases mortality risk for organ transplant recipients, study finds

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Study links longer hormone exposure to increased thyroid cancer risk in women

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Study finds hormone-disrupting chemicals in breast milk and infants' urine

+ Pharmaceuticals
Patient Daily | Jun 14, 2026

Study finds gaps in guideline-based testosterone prescribing practices

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily